Omega 3 fatty acids in cardiovascular disease risk factors: An updated systematic review of randomised clinical trials

Clinical Nutrition

Volumn 37, Issue 1, 2018, Pages 72-77

  Rangel Huerta, Oscar D ^a   Gil, Angel ^a,b  

^a UNIVERSITY OF GRANADA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Cardiovascular disease risk factors; Omega 3; Systematic review

Indexed keywords

DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; LIPID; OMEGA 3 FATTY ACID; TRIACYLGLYCEROL;

ANTIHYPERTENSIVE ACTIVITY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIET SUPPLEMENTATION; DIETARY INTAKE; DRUG MEGADOSE; HUMAN; HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA; INFLAMMATION; METABOLIC SYNDROME X; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SAMPLE SIZE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; DIET THERAPY; DIETARY SUPPLEMENT; RISK FACTOR;

CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 85020238166     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2017.05.015     Document Type: Review

References (45)

1. Burr, G., Burr, M., A new deficiency disease produced by the rigid exclusion of fat from the diet. J Biol Chem 82 (1929), 345–367.
2. Bang, H.O., Dyerberg, J., Nielsen, A.B., Plasma lipid and lipoprotein pattern in Greenlandic West-coast Eskimos. Lancet (London, England) 1 (1971), 1143–1145, 10.1016/S0140-6736(71)91658-8.
3. Dyerberg, J., Bang, H.O., Hjorne, N., Fatty acid composition of the plasma lipids in Greenland Eskimos. Am J Clin Nutr 28 (1975), 958–966.
4. ® REVEAL trial. Mol Cell Biochem 396 (2014), 9–22, 10.1007/s11010-014-2132-1.
5. Miller, P.E., Van Elswyk, M., Alexander, D.D., Long-chain Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and blood pressure: a meta-analysis of randomized controlled trials. Am J Hypertens 27 (2014), 885–896, 10.1093/ajh/hpu024.
6. Hooper, L., Thompson, R.L., Harrison, R.A., Summerbell, C.D., Moore, H., Worthington, H.V., et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database Syst Rev, 2004, CD003177, 10.1002/14651858.CD003177.pub2.
7. Skilton, M.R., Ayer, J.G., Harmer, J.A., Webb, K., Leeder, S.R., Marks, G.B., et al. Impaired fetal growth and arterial wall thickening: a randomized trial of omega-3 supplementation. Pediatrics 129 (2012), e698–703, 10.1542/peds.2011-2472.
8. Cabo, J., Alonso, R., Mata, P., Omega-3 fatty acids and blood pressure. Br J Nutr 107 (2012), S195–S200, 10.1017/S0007114512001584.
9. Delgado-Lista, J., Perez-Martinez, P., Lopez-Miranda, J., Perez-Jimenez, F., Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr 107:Suppl (2012), S201–S213, 10.1017/S0007114512001596.
10. Rangel-Huerta, O.D., Aguilera, C.M., Mesa, M.D., Gil, A., Omega-3 long-chain polyunsaturated fatty acids supplementation on inflammatory biomakers: a systematic review of randomised clinical trials. Br J Nutr 107:Suppl (2012), S159–S170, 10.1017/S0007114512001559.
11. Wang, Q., Liang, X., Wang, L., Lu, X., Huang, J., Cao, J., et al. Effect of omega-3 fatty acids supplementation on endothelial function: a meta-analysis of randomized controlled trials. Atherosclerosis 221 (2012), 536–543, 10.1016/j.atherosclerosis.2012.01.006.
12. Kotwal, S., Jun, M., Sullivan, D., Perkovic, V., Neal, B., Omega 3 fatty acids and cardiovascular outcomes: systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes 5 (2012), 808–818, 10.1161/CIRCOUTCOMES.112.966168.
13. Huang, H.-L., Chuang, L.-T., Li, H.-H., Lin, C.-P., Glew, R.H., Docosahexaenoic acid in maternal and neonatal plasma phospholipids and milk lipids of Taiwanese women in Kinmen: fatty acid composition of maternal blood, neonatal blood and breast milk. Lipids Health Dis, 12, 2013, 27, 10.1186/1476-511X-12-27.
14. Singhal, A., Lanigan, J., Storry, C., Low, S., Birbara, T., Lucas, A., et al. Docosahexaenoic acid supplementation, vascular function and risk factors for cardiovascular disease: a randomized controlled trial in young adults. J Am Heart Assoc, 2, 2013, e000283, 10.1161/JAHA.113.000283.
15. Kirkhus, B., Lamglait, A., Eilertsen, K.-E., Falch, E., Haider, T., Vik, H., et al. Effects of similar intakes of marine n-3 fatty acids from enriched food products and fish oil on cardiovascular risk markers in healthy human subjects. Br J Nutr 107 (2012), 1339–1349, 10.1017/S0007114511004508.
16. Phang, M., Lincz, L., Seldon, M., Garg, M.L., Acute supplementation with eicosapentaenoic acid reduces platelet microparticle activity in healthy subjects. J Nutr Biochem 23 (2012), 1128–1133, 10.1016/j.jnutbio.2011.06.006.
17. Raatz, S.K., Rosenberger, T.A., Johnson, L.K., Wolters, W.W., Burr, G.S., Picklo, M.J., Dose-dependent consumption of farmed atlantic salmon (Salmo salar) increases plasma phospholipid n-3 fatty acids differentially. J Acad Nutr Diet 113 (2013), 282–287, 10.1016/j.jand.2012.09.022.
18. Nilsson, A., Radeborg, K., Salo, I., Björck, I., Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J, 11, 2012, 99, 10.1186/1475-2891-11-99.
19. Alsaleh, A., Maniou, Z., Lewis, F.J., Hall, W.L., Sanders, T.A.B., O'Dell, S.D., Interaction between c-Src tyrosine kinase gene variant and fish oil intake influences blood pressure in healthy adults. J Nutr, 2014, 267–272, 10.3945/jn.113.185108.
20. Albert, B.B., Derraik, J.G.B., Brennan, C.M., Biggs, J.B., Garg, M.L., Cameron-Smith, D., et al. Supplementation with a blend of krill and salmon oil is associated with increased metabolic risk in overweight men. Am J Clin Nutr 102 (2015), 49–57, 10.3945/ajcn.114.103028.
21. Bragt, M.C.E., Mensink, R.P., Comparison of the effects of n-3 long chain polyunsaturated fatty acids and fenofibrate on markers of inflammation and vascular function, and on the serum lipoprotein profile in overweight and obese subjects. Nutr Metab Cardiovasc Dis 22 (2012), 966–973, 10.1016/j.numecd.2010.12.010.
22. Metkus, T., Timpone, J., Leaf, D., Goetz, M.B., Harris, W., Brown, T., Omega-3 fatty acid therapy reduces triglycerides and interleukin-6 in hypertriglyeridemic HIV patients. HIV Med 14 (2013), 530–539, 10.1111/hiv.12046.
23. Tani, S., Nagao, K., Matsumoto, M., Hirayama, A., Highly purified eicosapentaenoic acid may increase low-density lipoprotein particle size by improving triglyceride metabolism in patients with hypertriglyceridemia. Circ J 77 (2013), 2349–2357, 10.1253/circj.CJ-12-1401.
24. Paranandi, A., Asztalos, B.F., Mangili, A., Kuvin, J., Gerrior, J., Sheehan, H., et al. Short communication: effects of Omega-3 fatty acids on triglycerides and high-density lipoprotein subprofiles in HIV-infected persons with hypertriglyceridemia. AIDS Res Hum Retroviruses 30 (2014), 800–805, 10.1089/aid.2014.0005.
25. Dawczynski, C., Massey, K.A., Ness, C., Kiehntopf, M., Stepanow, S., Platzer, M., et al. Randomized placebo-controlled intervention with n-3 LC-PUFA-supplemented yoghurt: effects on circulating eicosanoids and cardiovascular risk factors. Clin Nutr 32 (2013), 686–696, 10.1016/j.clnu.2012.12.010.
26. Yamamoto, T., Kajikawa, Y., Otani, S., Yamada, Y., Takemoto, S., Hirota, M., et al. Protective effect of eicosapentaenoic acid on insulin resistance in hyperlipidemic patients and on the postoperative course of cardiac surgery patients: the possible involvement of adiponectin. Acta Med Okayama 68 (2014), 349–361.
27. Krantz, M.J., Havranek, E.P., Pereira, R.I., Beaty, B., Mehler, P.S., Long, C.S., Effects of omega-3 fatty acids on arterial stiffness in patients with hypertension: a randomized pilot study. J Negat Results Biomed, 14, 2015, 21, 10.1186/s12952-015-0040-x.
28. Ahmadi, A., Gharipour, M., Arabzadeh, G., Moin, P., Hashemipour, M., Kelishadi, R., The effects of Vitamin E and Omega-3 PUFAs on endothelial function among adolescents with metabolic syndrome. Biomed Res Int, 2014, 2014, 906019, 10.1155/2014/906019.
29. Tardivo, A.P., Nahas-Neto, J., Orsatti, C.L., Dias, F.B., Poloni, P.F., Schmitt, E.B., et al. Effects of omega-3 on metabolic markers in postmenopausal women with metabolic syndrome. Climacteric 18 (2015), 290–298, 10.3109/13697137.2014.981521.
30. McDonald, D.M., O'Kane, F., McConville, M., Devine, A.B., McVeigh, G.E., Platelet redox balance in diabetic patients with hypertension improved by n-3 fatty acids. Diabetes Care 36 (2013), 998–1005, 10.2337/dc12-0304.
31. Kondo, K., Morino, K., Nishio, Y., Kondo, M., Nakao, K., Nakagawa, F., et al. A fish-based diet intervention improves endothelial function in postmenopausal women with type 2 diabetes mellitus: a randomized crossover trial. Metabolism 63 (2014), 930–940, 10.1016/j.metabol.2014.04.005.
32. McEwen, B.J., Morel-Kopp, M.-C., Chen, W., Tofler, G.H., Ward, C.M., Effects of omega-3 polyunsaturated fatty acids on platelet function in healthy subjects and subjects with cardiovascular disease. Semin Thromb Hemost 39 (2013), 25–32, 10.1055/s-0032-1333309.
33. Laake, K., Seljeflot, I., Fagerland, M.W., Njerve, I.U., Arnesen, H., Solheim, S., Effects on serum fractalkine by diet and omega-3 fatty acid intervention: relation to clinical outcome. Mediat Inflamm, 2015, 2015, 373070, 10.1155/2015/373070.
34. Roncaglioni, M.C., Tombesi, M., Avanzini, F., Barlera, S., Caimi, V., Longoni, P., et al. n–3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 368 (2013), 1800–1808, 10.1056/NEJMoa1205409.
35. Gholamhosseini, S., Nematipour, E., Djazayery, A., Javanbakht, M.H., Koohdani, F., Zareei, M., et al. ω-3 fatty acid differentially modulated serum levels of IGF1 and IGFBP3 in men with CVD: a randomized, double-blind placebo-controlled study. Nutrition 31 (2015), 480–484, 10.1016/j.nut.2014.09.010.
36. Erkkilä, A.T., Schwab, U.S., Lehto, S., de Mello, V.D., Kangas, A.J., Soininen, P., et al. Effect of fatty and lean fish intake on lipoprotein subclasses in subjects with coronary heart disease: a controlled trial. J Clin Lipidol 8 (2014), 126–133, 10.1016/j.jacl.2013.09.007.
37. Bozcali, E., Babalik, E., Himmetoglu, S., Mihmanli, I., Toprak, S., ω-3 fatty acid treatment in cardiac syndrome X: a double-blind, randomized, placebo-controlled clinical study. Coron Artery Dis 24 (2013), 328–333, 10.1097/MCA.0b013e32835f3005.
38. Szabo de Edelenyi, F., Vergnaud, A.-C., Ahluwalia, N., Julia, C., Hercberg, S., Blacher, J., et al. Effect of B-vitamins and n-3 PUFA supplementation for 5 years on blood pressure in patients with CVD. Br J Nutr 107 (2012), 921–927, 10.1017/S0007114511003692.
39. Kirkegaard, E., Svensson, M., Strandhave, C., Schmidt, E.B., Jorgensen, K.A., Christensen, J.H., Marine n-3 fatty acids, atrial fibrillation and QT interval in haemodialysis patients. Br J Nutr 107 (2012), 903–909, 10.1017/S0007114511003771.
40. An, W.S., Lee, S.M., Son, Y.K., Kim, S.E., Kim, K.H., Han, J.Y., et al. Omega-3 fatty acid supplementation increases 1,25-dihydroxyvitamin D and fetuin-A levels in dialysis patients. Nutr Res 32 (2012), 495–502, 10.1016/j.nutres.2012.06.005.
41. Bello, K., Fang, H., Fazeli, P., Bolad, W., Corretti, M., Magder, L., et al. Omega-3 in SLE: a double-blind, placebo-controlled randomized clinical trial of endothelial dysfunction and disease activity in systemic lupus erythematosis. Rheumatol Int 33 (2013), 2789–2796, 10.1007/s00296-013-2811-3.Omega-3.
42. Hartweg, J., Farmer, A.J., Holman, R.R., Neil, H.A., Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes. Diabetologia 50 (2007), 250–258, 10.1007/s00125-006-0486-y.
43. Leslie, M.A., Cohen, D.J.A., Liddle, D.M., Robinson, L.E., Ma, D.W.L., A review of the effect of omega-3 polyunsaturated fatty acids on blood triacylglycerol levels in normolipidemic and borderline hyperlipidemic individuals. Lipids Health Dis, 14, 2015, 53, 10.1186/s12944-015-0049-7.
44. Chen, C., Yu, X., Shao, S., Effects of omega-3 fatty acid supplementation on glucose control and lipid levels in type 2 diabetes: a meta-analysis. PLoS One 10 (2015), 1–14, 10.1371/journal.pone.0139565.
45. Schirmer, S.H., Werner, C.M., Binder, S.B.G., Faas, M.E., Custodis, F., Böhm, M., et al. Effects of omega-3 fatty acids on postprandial triglycerides and monocyte activation. Atherosclerosis 225 (2012), 166–172, 10.1016/j.atherosclerosis.2012.09.002.